ArticleAmerican journal of cancer research2021

A novel selective AKR1C3-activated prodrug AST-3424/OBI-3424 exhibits broad anti-tumor activity.

Fanying Meng et al.PubMed ↗Full text ↗

No numbers read from the abstract.